Committee members will support Cerebra in its mission to change the future of sleep diagnosis and therapy 

January 12, 2021: Winnipeg, Manitoba. Cerebra, a leader in sleep science, today announces the formation of a Scientific Advisory Board in support of its mission to transform the diagnosis and treatment of major sleep disorders. Cerebra digital sleep analytics move beyond traditional scoring methods and sleep staging, providing automated, digital, and detailed analysis of brain activity during sleep.

“Our scientific advisory board will offer their deep experience in the study of sleep, sleep disorders, diagnosis and therapy to help Cerebra continue to evolve sleep science,” explains Dawson Reimer, President Cerebra. “And importantly, support the development of a personalized sleep care platform, improving the mental, physical and emotional health of those struggling with sleep.”

Cerebra Scientific Advisory Board members include:

  • Clete A. Kushida, MD, PhD
  • Richard Berry, MD, University of Florida
  • Thomas Penzel, PhD, Charité University Hospital
  • Célyne Bastien, PhD, Université Laval
  • David White, MD, Harvard Medical School

Clete A. Kushida, MD, PhD is an academic physician-scientist whose major accomplishments and roles include serving as past President of the World Sleep Society, the World Sleep Federation, the American Academy of Sleep Medicine (AASM), and founding President of the California Sleep Society. Dr. Kushida has authored or edited over 200 publications, including six books, and serves as editor-in-chief of the journal Sleep Science and Practice.

Areas of focus: Sleep apnea, sleep technology, narcolepsy/hypersomnias, and countermeasures for sleep loss

Dr. Richard Berry, MD, is Professor of Medicine at the University of Florida in Gainesville, Medical Director of the UF Health Sleep Center and Director of the UF Sleep Medicine Fellowship. His major accomplishments and roles include serving as Deputy Editor of the Journal of Clinical Sleep Medicine, Past President of the AASM Foundation, and serving on the AASM Board of Directors.  Dr. Berry was chair of the AASM Scoring Manual Committee for 10 years and lead author on a publication of the AASM Sleep Apnea Definitions task force.  He has written two popular sleep textbooks: The Fundamentals of Sleep Medicine and Sleep Medicine Pearls.

Areas of focus: Arousal from sleep, home sleep apnea testing, treatments for obstructive sleep apnea and polysomnography technology  

Thomas Penzel, Prof. Dr. currently serves as Scientific Chair of the Interdisciplinary Center of Sleep Medicine. He is also the Director of Research of the Interdisciplinary Sleep Medicine Center at the Charité – Universitätsmedizin Berlin (Germany). His major accomplishments include serving as President of the German Sleep Society and Adcom member of the IEEE Engineering in Medicine and Biology Society, an IEEE group dedicated to the study of Biomedical Engineering. Dr. Penzel is editor-in-chief of the journal Sleep and Breathing and has published more than 300 journal papers.

Areas of focus: sleep medicine, biomedical signals, wearables for sleep recording, the cardiovascular and the neural system related to the sleep-wake regulation, and pathophysiology of sleep disordered breathing.

Célyne Bastien PhD, is a Full Professor, School of Psychology, Laval University, and Researcher, Cervo Brain Research Centre. Dr. Bastien studies the psychological and physiological aspects of insomnia to understand its effects on people and to find ways of treating them. Dr. Bastien has conducted studies showing that the brains of insomniacs remain in a state of hypervigilance during sleep, and that these people respond differently to stimuli (sound or visual) during sleep, but also while awake. She is the director of the Human Neurosciences and Sleep Laboratory and has received CIHR grants to measure cortical activation in people with insomnia.

Areas of focus: Psychophysiological aspects of sleep; microstructure and quantitative analyses of sleep EEG; Insomnia and insomnia therapy; cortical activation and hyperarousal; event-related potentials in sleep and during wake; sleep perception; and sleep in the elderly.  

Dr. David White, MD, graduated from Emory University Medical School and completed training in Internal Medicine and Pulmonary Disease at the University of Colorado Health Sciences Center. He has held a number of positions at various universities over his career and is currently a Professor of Medicine, Part Time, at the Harvard Medical School and is the Sleep Consultant for RB Neuro Pharma. Some of his major accomplishments include being President of the American Academy of Sleep Medicine, Chairing the Task Force to write the research plan addressing sleep and its disorders for the National Institutes of Health, and being the Editor-in-Chief of the Journal SLEEP. He was also on the test writing committees for the American Board of Internal Medicine for both Pulmonary Disease and Sleep Medicine.

Areas of focus: Pathophysiology of disorders of breathing during sleep; sleep apnea phenotyping to guide therapy; simplified methods to diagnose and monitor sleep apnea and insomnia.

About Cerebra

Cerebra Health Inc. (Cerebra) is a Canadian digital health and virtual care company transforming the future of sleep diagnosis and therapy. Cerebra digital sleep analytics are used by researchers and clinicians around the world to gain greater insight into an individual’s sleep and enable the personalization of treatments for sleep disorders.

Cerebra Medical, a wholly owned subsidiary of Cerebra Health, operates an ISO 13485:2016 certified Quality Management System for the design, development, and manufacture of EEG sleep monitoring systems and medical device software for collection and analysis of physiological data recorded during sleep.  Cerebra Medical holds an MDSAP certificate in conformance with the requirements of Health Canada and FDA.